Rapid synthesis of triazole-modified resveratrol analogues via click chemistry

Journal of Medicinal Chemistry

Volumn 49, Issue 2, 2006, Pages 467-470

  Pagliai, Francesca ^a   Pirali, Tracey ^a   Del Grosso, Erika ^a   Di Brisco, Riccardo ^a   Tron, Gian Cesare ^a   Sorba, Giovanni ^a   Genazzani, Armando A ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RESVERATROL; RESVERATROL DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; CLICK; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; CYCLOADDITION; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STEREOISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 31544472391     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm051118z     Document Type: Article

References (30)

1. Ferrieres, J. The French paradox: lessons for other countries. Heart 2004, 90, 107-111.
2. Bradamante, S.; Barenghi, L.; Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 2004, 22, 169-188.
3. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beeoher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-220.
4. Shazib, P. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003, 17, 1975-1985.
5. Aggarwal, B.; Bhardwaj, A.; Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada, Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004, 24, 2783-2840.
6. Murias, M.; Handler, N.; Erker, T.; Pleban, K.; Ecker, G.; Saiko, P.; Szekeres, T.; Jager, W. Resveratrol analogues as selective cyclooxegenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 2004, 12, 5571-5578.
7. Scarlatti, F.; Sala, G.; Somenzi, G.; Signorelli, P.; Sacchi, N.; Ghidoni, R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 2003, 17, 2339-2341.
8. Bode, A. M.; Dong, Z. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 2000, 1, 181-188.
9. Mnjoyan, Z. H.; Fujise, K. Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53-p21-(WAF1/CIP1) pathway. Biochem. Biophys. Res. Commun. 2003, 311, 546-552.
10. Ulrich, S.; Wolter, F.; Stein, J. M. Molecular mechanisms of the chemopreventive effects of resveratrol and its anolagues in carcinogenesis. Mol. Nutr. Food Res. 2005, 49, 452-461.
11. Orsini, F.; Verotta, L.; Lecchi, M.; Restano, R.; Curia, G.; Redaelli, E.; Wanke, E. Resveratrol derivatives and their role us potassium channels modulators. J. Nat. Prod. 2004, 67, 421-426.
12. Klinge, C. M.; Blankenship, K. A.; Risinger, K. E.; Bhatnagar, S.; Noisin, E. L.; Surmmasekera, W. K.; Zhao, L.; Brey, D. M.; Keynton, R. S. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem. 2005, 280, 7460-7468.
13. (a) Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry on drug discovery. Drug Discovery Today 2003, 8, 1128-1137.
14. (b) Sivakumar, K.; Xie, P.; Cash, B. M.; Long, S.; Barnhill, H. N.; Wang, Q. A fluorogenic 1,3-dipolar cycloaddition reactions of 3-azidocoumarins and acetylenes. Org. Lett. 2004, 6, 4603-4606.
15. (c) Brik, A.; Muldoon, J.; Lin, Y. C.; Elder, J. H.; Goodsell, D. S.; Olson, A. J.; Fokin, V. V.; Sharpless, K. B.; Wong, C. H. Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors. ChemBioChem 2003, 4, 1246-1248.
16. (d) Best, M. D.; Brik, A.; Chapman, E.; Lee, L. V.; Cheng, W. C.; Wong, C. H. Rapid discovery of potent sulfotransferase inhibitors by diversity-oriented reaction in microplates followed by in situ screening. ChemBioChem 2004, 5, 811-819.
17. (e) Brik, A.; Alexandratos, J.; Lin, Y. C.; Elder, J. H.; Olson, A. J.; Wlodawer, A.; Goodsell, D. S.; Wong, C. H. 1,2,3-Triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. ChemBioChem 2005, 6, 1167-1169.
18. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem., Int. Ed. 2001, 40, 2004-2021.
19. (a) Rostovtsev, V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise Huisgen cycloaddition process: copper (I) catalyzed regioselective "ligation" of azide and terminal alkynes. Angew. Chem., Int. Ed. 2002, 41, 2596-2599.
20. (b) Tornøe, C. W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-Triazole by regiospecific copper (I)-catalyzed 1,3-dipolar cycloaddition of terminal alkynes to azide. J. Org. Chem. 2002, 67, 3057-3064.
21. 1-catalyzed azide-alkyne cycloaddition reaction. Angew. Chem., Int. Ed. 2005, 44, 2210-2215.
22. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
23. (a) Pettit, G. R.; Grealish, M. P.; Jung, M. K.; Hamel, E.; Pettit, R. K.; Chapuis, J. C.; Schmidt, J. M. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resveratrin phosphate. J. Med. Chem. 2002, 45, 2534-2542.
24. (b) Roberti, M.; Pizzirani, D.; Simoni, D.; Rondanin, R.; Baruchello, R.; Bonora, C.; Buscami, F.; Grimaudo, S.; Tolomeo, M. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 2003, 46, 3546-3554.
25. (c) Cardile, V.; Lombardo, L.; Spatafora, C.; Trincali, C. Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorg. Chem. 2005, 33, 22-33.
26. Miller, A. O.; Furin, G. G. Reaction of polyfluoro aromatic compounds with sodium nitrite. Zh. Org. Khim. 1989, 25, 355-357.
27. Azios, N. G.; Dharmawardhane, S. F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia 2005, 7, 128-140.
28. Pozo-Guisado, E.; Alvarez-Barrientos, A.; Mulero-Navarro, S.; Santiago-Josefat, B.; Fernandez-Salguero, P. M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 2002, 64, 1375-1386.
29. Bernhard, D.; Tinhofer, I.; Tonko, M.; Hübl, H.; Ausserlechner, M. J.; Greil, R.; Kofler, R.; Csordas, A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 2000, 7, 834-842.
30. Hsieh, H. P.; Liou, J. P.; Mahindroo, N. Pharmaceutical design of antimitotic agents based on combretastatins. Curr. Pharm. Des. 2005, 11, 1655-1677.